利多卡因与地佐辛对丙泊酚注射痛预防作用的比较

目的比较预先注射利多卡因或地佐辛对预防丙泊酚注射痛的价值。方法本研究是随机、双盲、对照研究。将ASAⅠ^Ⅲ级的择期手术患者180例,按随机序列数字法分为三组,每组60例。L组为利多卡因组,预先注射2%利多卡因40 mg;D组为地佐辛组,预先注射地佐辛5 mg;C组为生理盐水对照组。记录各组在注射药物前后SBP、DBP、HR;静脉注射丙泊酚过程中询问疼痛情况,按照不痛、轻度疼痛、中度疼痛、重度疼痛记录疼痛程度。结果 L、D组的丙泊酚注射痛发生率显著低于C组(P<0.01),L组的注射痛发生率显著低于D组(P<0.05)。结论预先注射利多卡因能有效地抑制或减轻丙泊酚注射痛,其效果优于预先注射地佐辛。     

舒芬太尼与瑞芬太尼复合丙泊酚用于肝肿瘤经皮微波凝固麻醉的研究

目的研究舒芬太尼或瑞芬太尼复合丙泊酚全凭静脉麻醉下肝肿瘤经皮微波凝固治疗对患者循环功能、呼吸、复苏质量及术后疼痛等方面的影响。方法肝肿瘤患者40例,随机分成两组,舒芬太尼组(S组,n=20),瑞芬太尼组(R组,n=26)。S组舒芬太尼0.2μg/kg诱导,0.1~0.2μg/(kg.h)维持;R组瑞芬太尼1μg/kg诱导,0.1~0.2μg/(kg.m in)维持。两组均复合使用丙泊酚:诱导1.0mg/kg,维持3.0~6.0 mg/(kg.h)。记录麻醉诱导前、麻醉诱导后5 m in、治疗开始后5 m in、停药后5 m in的血流动力学变化。术毕病人Ram esay镇静评分、VAS评分及病人总体满意度。结果S组患者术中、术后血流动力学无明显差异,满意度高。R组患者用药后HR、SBP、DBP下降明显(P<0.01),术毕疼痛发生率高,满意度低。结论舒芬太尼配伍丙泊酚术中血流动力学稳定,术后有良好的镇静、镇痛,病人满意度高。     

丙泊酚复合小剂量舒芬太尼用于无痛胃镜临床观察

目的探讨丙泊酚复合舒芬太尼用于门诊无痛胃镜的安全性和有效性。方法ASAⅠ-Ⅱ级要求行门诊无痛胃镜检查的患者120例,随机分为3组,即分为丙泊酚+生理盐水组(P组)、丙泊酚复合芬太尼组(PF组)和丙泊酚复合舒芬太尼组(PS组),每组40例。各组在静脉注射丙泊酚前分别静脉注射生理盐水2ml、芬太尼0.5mg、舒芬太尼0.1μg/kg,待患者睫毛反射消失后插入胃镜,检查过程中连续监测HR、MAP、SpO2,记录丙泊酚的总量、意识恢复时间、定向力恢复时间、胃镜操作时间、术中知晓发生率等,观察注药时静脉疼痛、胃镜检查中呛咳、体动反应、头晕的情况。结果三组患者术中HR、MAP、SpO2与术前或术后相比均明显降低(P<0.05),各组之间HR、MAP、SpO2比较差异均有统计学意义(P<0.05),意识恢复时间、定向力恢复时间P组与PF、PS组相比明显延长,差异具有统计学意义(P<0.05),PF、PS组之间也有统计学意义(P<0.05)。丙泊酚用量P组比PF、PS组增加,差异具有统计学意义(P<0.05),PF、PS组之间无统计学差异。结论丙泊酚复合小剂量舒芬太尼(0.1μg/kg)不仅可以减少丙泊酚用量、有效降低呼吸抑制等副反应,而且能缩短苏醒时间,使麻醉更加平稳。     

3种镇痛药在无痛肠镜检查中的镇痛效果及安全性比较

目的比较芬太尼、瑞芬太尼与舒芬太尼3种镇痛药在无痛肠镜检查中的镇痛效果及安全性。方法 150例拟行无痛肠镜检查的患者,随机分为芬太尼组(PF组)、瑞芬太尼组(PR组)和舒芬太尼组(PS组),每组50例。各组分别缓慢静注芬太尼0.8μg/kg、瑞芬太尼0.5μg/kg、舒芬太尼0.08μg/kg,后再静脉匀速推注丙泊酚1.5 mg/kg,睫毛反射消失后开始检查操作。术中视情况追加丙泊酚0.5～1.0 mg/kg。监测用药前、插镜时、给药5 min、术毕清醒时的心率(heart rate,HR)、收缩压(systolic blood pressure,SBP)、舒张压(diastolic blood pressure,DBP)、脉搏血氧饱和度(pulse oxygen saturation,SpO2),并记录停药睁眼时间、定向力恢复时间、丙泊酚总用量、清醒时疼痛评分、呼吸抑制发生情况。结果①各组内给药后各个时间点SBP、DBP、HR与给药前相比均下降(P<0.05),SpO2变化无统计学意义(P>0.05);各组间两两比较,相同时间点观察指标差异无统计学意义(P>0.05)。②与其他两组比较PS组疼痛评分最低(P<0.05),PF、PR两组相比差异无统计学意义(P>0.05)。③与其他两组比较PR组停药睁眼时间及定向力恢复时间最短(P<0.05),与其他两组比较PS组显著延长(P<0.05)。④与其他两组比较PR组丙泊酚总用量最少(P<0.05),PF、PS两组相比差异无统计学意义(P>0.05)。⑤PS组、PR组体动发生率明显低于PF组(P<0.05),3组呼吸抑制发生率差异无统计学意义(P>0.05)。结论芬太尼、瑞芬太尼、舒芬太尼3种镇痛药均能够安全用于无痛肠镜检查,但三者的镇痛效果、苏醒时间以及能否减少复合药丙泊酚的总用量等方面存在差异,麻醉医师应评估患者情况后合理选择镇痛药物。     

蛛网膜下腔注射利多卡因和舒芬太尼对肛肠术后恢复的影响

 目的 比较联合应用小剂量利多卡因和舒芬太尼同单纯应用利多卡因进行腰麻对门诊患者肛肠手术后恢复时间的影响.方法 选择49例ASAⅠ～Ⅲ级,20～69岁,准备在腰麻下行门诊肛肠手术的患者,随机分为两组:A组(n=28)蛛网膜下腔给予小剂量利多卡因15 mg,舒芬太尼10 μg;B组(n=21)单纯给予利多卡因50 mg.记录恢复运动的时间,瘙痒发生率和其他变化.结果 蛛网膜下腔联合注射小剂量利多卡因和舒芬太尼明显较单纯注射利多卡因恢复运动快(P<0.01).A组50%出现瘙痒.结论 蛛网膜下腔联合注射利多卡因和舒芬太尼比单纯注射利多卡因的运动恢复时间明显缩短.除了瘙痒不良反应外,A组麻醉效果较好.     

神经外科手术病人丙泊酚靶控输注复合舒芬太尼和芬太尼麻醉的效果比较

目的评价神经外科手术病人丙泊酚靶控输注复合舒芬太尼或芬太尼麻醉的效果。方法择期神经外科手术病人40例,ASA I级或II级,随机分为两组:丙泊酚-舒芬太尼组(S组)和丙泊酚-芬太尼组(F组),每组20例。术中S组持续输注舒芬太尼0.02~0.05μg/(kg.m in),F组单次静脉注射芬太尼,每次1~2μg/kg。分别于麻醉诱导前(T0,基础值)、气管插管前即刻(T1)、气管插管后即刻(T2)、上头架后即刻(T3)、切皮后即刻(T4)、颅内占位切除约一半时(T5)、关颅头皮皮下缝合开始后即刻(T6)、拔除气管导管即刻(T7)和拔除气管导管后30m in(T8)各时间点记录血流动力学指标。术后恢复阶段观察病人的自主呼吸恢复时间、轻唤睁眼时间、拔管时间,并于拔管后5 m in记录病人的警觉/镇静评分(OAA/S评分)。结果F组在T2、T3、T6时MAP高于S组(P<0.05);S组在T3、T6时的HR低于F组(P<0.05);F组的自主呼吸恢复时间、轻唤睁眼时间、拔管时间较S组延长(P<0.05);F组拔管后5 m in OAA/S评分低于S组(P<0.05)。两组间术中、术后并发症发生率比较差异无统计学意义(P>0.05)。结论与芬太尼相比较,在神经外科手术时联合应用丙泊酚和舒芬太尼进行全凭静脉麻醉(TIVA),能提供更为稳定的血流动力学,病人术后苏醒快、苏醒质量高,麻醉可控性更好。     

无痛分娩中应用不同剂量艾司氯胺酮效果及对产后抑郁影响

目的 探讨不同剂量艾司氯胺酮应用于无痛分娩中的效果及对产后抑郁的影响。方法 选取自2020年12月至2022年12月于山东大学齐鲁医院德州医院接受无痛分娩的81例产妇为研究对象。随机将研究对象分为舒芬太尼组、低剂量组、高剂量组,每组各27例。3组均行硬膜外麻醉,舒芬太尼组在此基础上联合舒芬太尼0.2μg/ml,低、高剂量组则在此基础上分别联合艾司氯胺酮50.0 mg、100.0 mg。比较3组镇痛前、后的疼痛情况,不同时间点血流动力学指标,麻醉不良反应发生率,以及产后抑郁情况。结果 镇痛后,3组疼痛视觉模拟量表(VAS)评分均较镇痛前降低,差异均有统计学意义(P<0.05);低、高剂量组的VAS评分低于舒芬太尼组,且高剂量组低于低剂量组,组间比较,差异均有统计学意义(P<0.05)。镇痛前、后不同时间点,3组的平均动脉压、心率、胎心率比较,差异均无统计学意义(P>0.05)。高剂量组麻醉不良反应发生率高于舒芬太尼组及低剂量组,组间比较,差异均有统计学意义(P<0.05);舒芬太尼组与低剂量组麻醉不良反应发生率比较,差异无统计学意义(P>0.05)。低、高剂...     

丙泊酚超射技术在老年无痛胃镜检查麻醉中的应用

目的探讨丙泊酚超射技术在老年人群无痛胃镜检查中的麻醉效果。方法将拟行上消化道内镜检查、ASAⅡ级、年龄55～81岁的病人80例,随机分成两组:每组各40例。T组(TCI组):舒芬太尼0.1μg/kg+丙泊酚0.5 mg/kg静注,S组(Super Injection组):舒芬太尼0.1μg/kg+丙泊酚0.5 mg/kg超射,观察NBP、HR、SpO2、丙泊酚用量、苏醒时间、体动以及心动过缓等术中并发症的发生率。结果 S组的丙泊酚用量较T组显著减少(P<0.05),S组的苏醒时间较T组显著缩短(P<0.05),两组的术中并发症的发生率差异无统计学意义(P>0.05)。结论 0.1μg/kg舒芬太尼复合0.5 mg/kg丙泊酚超射适用于老年无痛胃镜检查术。     

纳洛酮与舒芬太尼混合输注在老年患者胃食管反流病射频手术的应用

目的 评价纳洛酮与舒芬太尼混合液在老年患者胃食管反流病射频手术的麻醉效果。方法 择期行胃镜下射频治疗的老年患者（年龄≥65）120例随机分为对照组（舒芬太尼复合丙泊酚麻醉)和干预组（舒芬太尼纳洛酮混合液复合丙泊酚麻醉)。记录术中平均血压较基线值波动大于20%的例数、平均动脉压和心率、BIS值;记录苏醒时间、丙泊酚用量和术后1 h痛觉(Visual Analogue Score,VAS)评分等。结果 对照组（26例,43%）血压波动大于20%的例数大于干预组（10例,17%）（P=0.001）;干预组BIS值高于对照组（P<0.01）;干预组丙泊酚的用量小于对照组用量（P<0.01）,干预组苏醒时间短于对照组（P<0.01）,干预组术后1 h VAS评分低于对照组（P=0.005）。结论 纳洛酮舒芬太尼混合输注镇痛效果增强,可使丙泊酚用量减少,血流动力学更稳定,苏醒时间缩短。     

靶控输注舒芬太尼复合丙泊酚联合硬膜外麻醉用于上腹部手术的麻醉效果观察

目的研究靶控输注舒芬太尼复合丙泊酚用于胰腺手术的麻醉效果以及硬膜外0.375%罗哌卡因用于胰腺手术时对血流动力学和舒芬太尼的需求量的影响。方法胰腺手术患者40例,ASAⅠ或Ⅱ级,手术持续时间1.5～4 h,随机分为硬膜外(生理盐水)、舒芬太尼组(S组)和硬膜外(0.375%罗哌卡因)、舒芬太尼组(R组)。全麻诱导采用靶控输注舒芬太尼和丙泊酚,意识消失(呼之不应)后静脉注射罗库溴铵0.6 mg/kg,当BIS值达到40～50时行气管插管,机械通气。气管插管后,调节丙泊酚靶浓度维持BIS在40～50,舒芬太尼靶浓度则根据动脉血压和心率来调节。记录两组入室时(基础值)、插管前即刻、插管后2 min、切皮即刻、剖腹探查即刻、手术1 h、拔管即刻的SBP、DBP、MAP、HR、BIS及舒芬太尼Ce(SCe)与丙泊酚Ce(PCe)。同时记录诱导时舒芬太尼和丙泊酚的总量。结果与S组比较,R组在切皮即刻、剖腹探查即刻、手术1 h、拔管即刻SCe降低(P<0.05)。与基础值比较,两组插管前即刻、手术1 h、拔管即刻SBP、DBP、MAP、HR均降低(P<0.05),两组插管后2 min、切皮即刻、剖腹探查即刻HR均降低(P<0.05);与S组比较,R组插管后2 min、切皮即刻、剖腹探查即刻、手术1 h、拔管即刻SBP均降低(P<0.05),剖腹探查即刻、手术1 h DBP、MAP均降低(P<0.05),插管后2 min、切皮即刻、剖腹探查即刻、手术1 h、拔管即刻HR均降低(P<0.05)。两组丙泊酚诱导和维持的量相比,差异无统计学意义(P>0.05)。两组舒芬太尼诱导剂量相比,差异也无统计学意义(P>0.05),维持剂量在R组显著减少。结论硬膜外0.375%罗哌卡因能够减轻胰腺手术应激反应,同时减少全麻药舒芬太尼的用量。     

利多卡因宫腔内注射及复方萘普生栓用于人工流产镇痛的随机对照研究

目的探讨利多卡因宫腔内注射与经直肠给予萘普生栓对早孕人工流产患者的镇痛效果。方法 224例孕6～12周人工流产患者,随机分为四组,Ⅰ组接受利多卡因宫腔内注射,同时经直肠给予萘普生栓;Ⅱ组接受利多卡因宫腔内注射以及安慰剂栓;Ⅲ组为生理盐水宫腔内注射,同时经直肠予以萘普生栓;Ⅳ组仅给予生理盐水宫腔内注射及安慰剂栓。以视觉模拟评分法(VAS)观察患者术中扩张宫颈时、术后即刻、术后30 min及术后60 min的疼痛程度。结果Ⅰ、Ⅱ、Ⅲ组与Ⅳ组相比,无论术中术后VAS评分均有显著下降,术后即刻VAS评分Ⅰ、Ⅱ、Ⅲ组无差别,单独使用萘普生的实验组扩宫时VAS评分高于单独使用利多卡因组,但术后VAS评分则相反,两者联合使用时术中术后VAS评分均为最低,且没有人流综合征发生。结论使用2%利多卡因6ml宫腔注射用于人工流产可以达到满意的镇痛效果,无副作用,加用萘普生栓可以进一步减轻术后的疼痛。     

地佐辛与舒芬太尼预防阑尾切除术内脏牵拉反应效果的比较

目的观察地佐辛与舒芬太尼静脉辅助用药预防硬膜外麻醉下阑尾切除术中内脏牵拉反应的效果及安全性。方法将40例拟行阑尾切除术的ASAⅠ～Ⅱ级患者,随机分为地佐辛组(D)和舒芬太尼组(S),每组20例。经T11～12椎间隙行硬膜外穿刺置管,麻醉平面固定后,切皮前D组静注地佐辛0.1 mg/kg,S组静注舒芬太尼0.2μg/kg。两组均不吸氧。记录用药前后SPO2变化及牵拉腹膜、阑尾,擦拭腹腔时的牵拉痛、恶心呕吐等不良反应,并评估二者预防内脏牵拉反应的效果及安全性。结果 D组及S组预防内脏牵拉反应的效果均良好,两组比较,差异无统计学意义(P>0.05),用药后5 min S组患者的SPO2低于D组(P<0.05)。结论地佐辛与舒芬太尼预防内脏牵拉反应的效果良好,且作用相当,但地佐辛的呼吸抑制作用轻,相对安全。     

Intraarterial lidocaine for pain control after uterine artery embolization for leiomyomata

PURPOSE: To evaluate the effectiveness of intraarterial lidocaine in controlling pain after uterine artery embolization (UAE). MATERIALS AND METHODS: In this double-blind prospective study, patients undergoing UAE received preservative-free 1% lidocaine or saline solution (control) in the uterine arteries before embolization. Postprocedural pain was managed with patient-controlled intravenous morphine. Attempted doses, number of doses received, total morphine dose, and maximum pain numeric rating scale (NRS) score during the postprocedural hospitalization were recorded and compared. Three-month follow-up magnetic resonance (MR) imaging and symptomatic questionnaires were collected and compared. RESULTS: Ten patients received lidocaine and eight patients received placebo. Moderate to severe vasospasm was noted in seven patients after lidocaine injection, whereas no vasospasm was noted in the placebo group (P =.004). Patients in the lidocaine group had lower NRS pain scores than those in the placebo group (P =.012), whereas there was no difference in morphine requirement between treated patients and control subjects. The study was terminated after 18 patients were treated as a result of unexpected vasospasm. CONCLUSIONS: Intraarterial 1% lidocaine is associated with moderate to severe vasospasm. Lidocaine significantly lowers subjective pain, but there is no difference in analgesic requirements. The routine use of intraarterial lidocaine is not recommended for pain control until the long-term effects of vasospasm on outcome is known.     

舒芬太尼与瑞芬太尼抑制无痛人工流产术后宫缩痛的临床效果比较

目的比较舒芬太尼和瑞芬太尼应用于人工流产术对术后宫缩痛的抑制作用。方法选择门诊自愿要求无痛人工流产术患者120例,随机分为3组（每组40例）。S组：舒芬太尼0．1～0．2μg／kg,异丙酚1～2mg／kg：R组：瑞芬太尼1-2μg／kg,异丙酚1-2mg／kg;P组：单纯异丙酚1-2mg／kg。观察术前及术中BP、HR、SpO2,记录异丙酚的总量,意识恢复时间,定向力恢复时间,术中呼吸抑制,术后宫缩痛的发生率及恶心呕吐等不良反应。结果3组BP、HR与术前比较有所降低（P〈0．05）,S组和R组异丙酚总用量减少,患者意识恢复时间及定向力恢复时间缩短,与P组比较有显著性差异（P〈0．05）,S组术后宫缩痛发生率明显低于R组和P组（P〈0．05）,S组和R组的术中躁动发生少于P组。结论舒芬太尼用于无痛人工流产术镇痛效果确切,术中呼吸抑制发生率低,能有效地抑制或减轻术后宫缩痛。     

不同剂量罗哌卡因腰硬联合麻醉对剖宫产产妇循环功能的影响

目的探讨不同剂量的罗哌卡因腰硬联合麻醉对剖宫产产妇循环功能的影响。方法选择90例择期行剖宫产术的孕产妇,按数字表法随机分为三组,行腰麻-硬膜外联合麻醉(CSEA),分别在蛛网膜下腔注入0.5%罗哌卡因(75 mg罗哌卡因+0.9%生理盐水15 ml)2.0 ml(A组)、1.8 ml(B组)和1.6 ml+硬膜外2%盐酸利多卡因3 ml(C组)。记录各组麻醉至手术开始的时间和手术的时间;观察各组麻醉阻滞效果、麻黄碱用量和硬膜外追加2%利多卡因情况;记录各组产妇在麻醉前、麻醉后仰卧、麻醉后5 min、麻醉后10 min、娩婴各时间点心率、血压的变化情况;记录产妇恶心、呕吐、低血压等情况。结果麻醉后5 min及10 min收缩压C组与A组比较,差异有统计学意义(P<0.05);娩婴时收缩压C组与A、B组比较,差异有统计学意义(P<0.05);麻醉后10 min舒张压C组与A组比较,差异有统计学意义(P<0.05);麻黄碱用量C组低于A、B组,差异有统计学意义(P<0.05);低血压发生率A、B组高于C组,差异有统计学意义(P<0.05);A、B两组各项指标比较,差异均无统计学意义。结论蛛网膜下腔给予罗哌卡因小剂量腰麻1.6 ml(8 mg)复合硬膜外追加2%盐酸利多卡因3 ml,对剖宫产产妇循环功能影响最小,副作用发生率最低。     

Paracetamol as a prophylactic analgesic for hysterosalpingography: a double blind randomized controlled trial

AIM: To evaluate the effectiveness of paracetamol as a prophylactic analgesic for hysterosalpingography (HSG).DESIGN: A prospective double blind randomized controlled trial comparing one 1 g of paracetamol (SmithKline Beecham, Brentford, U.K.) to placebo taken 30 min before HSG. One hundred consecutive out-patients were studied prospectively. The analgesic effectiveness during the procedure and at 24 h and 1 week post procedure was analysed by a postal pain score questionnaire. Additional data on the ethnicity of the patient, sex and level of experience of the radiologist performing the hysterosalpingogram, the parity of the patient, the ease of the procedure, and whether pathology was identified were also recorded. RESULTS: Eighty-eight patients (88%) replied, 39 (44%) received paracetamol and 49 placebo (56%). During the procedure 3/39 (7%) of women in the paracetamol group were pain-free compared to 9/49 (18%) in the placebo group, which was not significant (P = 0.11). At 24 h, 15/39 (38%) of women in the paracetamol group were pain-free compared to 20/49 (41%) in the placebo group, which was not significant (P = 0.82). At 1 week, 27/39 (69%) of women in the paracetamol group were pain-free compared to 29/49 (59%) in the placebo group, which was not significant (P = 0.33). No significant difference in mean pain scores was determined during the procedure (P = 0.91), or at 24 h post procedure (P = 0.94). Similarly, no difference in mean pain scores was identified with regard to the ethnicity of the patient, the sex of the radiologist performing the procedure, the level of experience of the radiologist performing the procedure, or whether pathology was present or not. Difficult cannulations were associated with higher mean pain scores, however, there was no difference in mean pain scores between the paracetamol or placebo groups for both easy and difficult cannulations. CONCLUSION: Paracetamol is not effective as a prophylactic analgesic for HSG. If a prophylactic analgesic is considered necessary for pain relief during HSG we recommend that a non-steroidal anti-inflammatory drug (NSAID) is used.     

补充大豆多肽对中长跑运动员训练期生化指标的影响

目的 :观察大豆多肽固体饮料对耐力项目运动员促进恢复的作用。方法 :2 1名男性省级中长跑运动员随机分为对照组 (n =7)、补糖组 (n =6 )和补肽组 (n =8)进行为期 4周的大强度训练 ,补肽组每天训练课后补充含有 8g大豆多肽和 35g糖的运动饮料 ,补糖组服用含有 35g糖的饮料 ,对照组服用外观及口感与大豆多肽饮料相近的安慰剂。实验前、训练两周后及实验后对受试对象的体成分、RPE等级和血液生化指标进行测试。结果 :补肽组运动后的体重、瘦体重比实验前明显提高 (P <0 0 5 ) ,血清睾酮水平比对照组显著提高 (P <0 0 5 ) ,而补肽组RPE等级显著下降 (P <0 0 1) ,同时血清肌酸激酶亦下降 (P <0 0 5 )。结论 :服用大豆多肽可促进中长跑运动员瘦体重的增加、提高血清睾酮的水平以及降低训练后RPE的等级 ,提示大豆多肽可促进蛋白质的合成 ,并具有一定的抗疲劳作用。此外摄入大豆多肽可降低中长跑运动员运动后血清肌酸激酶的水平 ,提示大豆多肽有促进骨骼肌损伤组织的修复以及减少细胞内肌酸激酶外渗的作用     

Saphenous nerve block is an effective regional technique for post-menisectomy pain

In this study we have evaluated the post menisectomy pain relief offered by Saphenous nerve block. This study was planned on 40 patients with a pre-operative and post operative diagnosis of medial meniscus lesion undergoing partial menisectomy arthroscopically. Patients were randomized into 2 groups where Group I received a preoperative Saphenous block while group 2 did not receive a peripheral block, but received 1 ml of saline as placebo injection. After blocks both groups received general anesthesia and IV patient controlled analgesia (PCA) with tramadol for post operative pain relief. Patients rest and activity pain scores were evaluated on post operative 0, 2, 4, 6, 12 and 24 h using visual analog scale (VAS). Total tramadol consumption as well as pain at rest, when weight bearing and the need for external support while walking were recorded. Group I VAS scores were statistically lower then group II during the time of observation periods at rest as well as active movement periods. Tramadol consumption through IV PCA was statistically significantly lower in group I than in group II (P < 0.05). Pain during walking measured at 24 h was significantly different with better results in group I (P < 0.001). Saphenous nerve block is used for different indications; it can also be a good analgesic method for arthroscopic interventions. We have shown it to be effective after medial partial menisectomies. According to our knowledge this report is the first one utilizing saphenous nerve block for pain after arthroscopic medial menisectomy.     

Intraarterial Lidocaine for Pain Control in Uterine Artery Embolization: A Prospective,Randomized Study

Purpose

To assess efficacy of two different techniques of lidocaine injection in the uterine arteries to reduce pain following uterine artery embolization (UAE) for leiomyomas.